Samantha Prout
CIK 1743122 · Chief Accounting Officer · last filed 2026-04-27
Samantha Prout is a Chief Accounting Officer who has filed 26 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing shows the insider disposed of $1.8M of FOLD on Apr 27, 2026. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
26
-$1.40M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Chief Accounting Officer | 0 | $14.49 | $0 | -$1.40M | 26 | 2026-04-27 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-27 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Disp (D) | −125,951 | -$1.83M | EDGAR |
| 2026-01-06 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −15,683 | -$223.8K | EDGAR |
| 2025-12-03 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +32,193 | $0 | EDGAR |
| 2025-02-13 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +13,916 | -$129.2K | EDGAR |
| 2025-01-06 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +21,599 | -$122.1K | EDGAR |
| 2024-04-16 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −7,027 | -$74.9K | EDGAR |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −32,104 | -$449.5K | EDGAR |
| 2024-01-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −9,438 | -$127.6K | EDGAR |
| 2024-01-03 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +583 | -$350.1K | EDGAR |
| 2023-12-28 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −7,659 | -$107.2K | EDGAR |